Cargando…
Insulin allergy and resistance successfully treated by desensitisation with Aspart insulin
A 25-year-old, with type I Diabetes Mellitus with a previous diagnosis of Protamine Allergy but not to human Insulin, started to notice anaphylactic reactions inmmediatly after bolus with Insulin. Skin prick and intradermal test were positive to all insulins. Skin tests to other potential allergens...
Autores principales: | Matheu, Victor, Perez, Eva, Hernández, Marta, Díaz, Elisa, Darias, Ricardo, González, Abel, García, Jose C, Sánchez, Inmaculada, Feliciano, Laura, Caballero, Agueda, de la Torre, Fernando |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1352375/ https://www.ncbi.nlm.nih.gov/pubmed/16375762 http://dx.doi.org/10.1186/1476-7961-3-16 |
Ejemplares similares
-
Successful cholecalciferol desensitisation in a case of delayed hypersensitivity
por: Anantharajah, Anthea, et al.
Publicado: (2019) -
Omalizumab for successful chemotherapy desensitisation: What we know so far
por: Bumbacea, Roxana Silvia, et al.
Publicado: (2021) -
Clinical Pharmacology of Fast-Acting Insulin Aspart Versus Insulin Aspart Measured as Free or Total Insulin Aspart and the Relation to Anti-Insulin Aspart Antibody Levels in Subjects with Type 1 Diabetes Mellitus
por: Haahr, Hanne, et al.
Publicado: (2018) -
Cost-effectiveness of insulin degludec/insulin aspart versus biphasic insulin aspart in Chinese population with type 2 diabetes
por: Luo, Qiong, et al.
Publicado: (2022) -
Diabetic Ketosis Caused by the Insulin Analog Aspart–Induced Anti-Insulin Antibody: Successful Treatment With the Newest Insulin Analog Glulisine
por: Yanai, Hidekatsu, et al.
Publicado: (2011)